top
Search terms
Results 1 - 10 of 109 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 11
Ehjournal

Introduction Despite the same electrophysiological abnormality, the risk of stroke and systemic embolism in atrial fibrillation (AF) ranges from <1%/year to >20%/year and can be assessed by simple ...

European Heart Journal, CURRENT OPINION, Raffaele De Caterina, A. John Camm

Date : 14/12/2014 Item size : 431415 bytes
Ehjournal

Abstract Aims Although non-vitamin K antagonist oral anticoagulants are recommended for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) based on clinical trial results, ...

European Heart Journal, FASTTRACK ESC Clinical Registry, A. John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Silvia Kuhls, Martin van Eickels, Alexander G.G. Turpie

Date : 07/04/2016 Item size : 258982 bytes
Ehjournal

Atrial fibrillation (AF) is the most common sustained arrhythmia being present in 1.52% of the population and has been found to occur more frequently in oncology patients.1 Cancer and cancer therapy ...

European Heart Journal, CardioPulse, José L Zamorano

Date : 21/09/2016 Item size : 127251 bytes
Ehjournal

The Task Force included cardiologists with varying areas of expertise, cardiac surgeons, stroke neurologists, and specialist nurses. Risk factors for atrial fibrillation include age, hypertension, ...

European Heart Journal, Issue @ A Glance, Thomas F. Lüscher

Date : 07/10/2016 Item size : 207219 bytes
Ehjournal

Atrial fibrillation (AF) patients with low education miss treatment targets more often Patients with no schooling benefit least from oral anticoagulants, revealed a European Heart Rhythm Association ...

European Heart Journal, CardioPulse

Date : 07/10/2016 Item size : 121322 bytes
Ehjournal

In most countries aspirin was available as an over-the-counter remedy well before its widespread use in cardiovascular disease, which probably contributed to its widespread acceptability. [...]many ...

European Heart Journal, CURRENT OPINION, S. Ben Freedman, Bernard J. Gersh, Gregory Y. H. Lip

Date : 14/03/2015
Ehjournal

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET ...

European Heart Journal, Atrial fibrillation, Günter Breithardt, Helmut Baumgartner, Scott D. Berkowitz, Anne S. Hellkamp, Jonathan P. Piccini, Susanna R. Stevens, Yuliya Lokhnygina, Manesh R. ...

Date : 14/12/2014
Ehjournal

Relative to warfarin, non-vitamin K oral anticoagulants (NOACs) are at least as good at preventing stroke or systemic embolism, cause less haemorrhagic stroke, and result in modestly lower ...

European Heart Journal, Editorial, Sean D. Pokorney, Christopher B. Granger

Date : 14/06/2015
Ehjournal

Prof. Gregory Lip discusses how to keep the decision-making process for choosing an oral anticoagulant simple and practical Stroke prevention is the cornerstone of the management of atrial ...

European Heart Journal, CardioPulse, Gregory Y. H. Lip

Date : 01/01/2017
Ehjournal

Prof. Gregory Lip discusses how to keep the decision-making process for choosing an oral anticoagulant simple and practical Stroke prevention is the cornerstone of the management of atrial ...

European Heart Journal, Lip, Gregory Y. H.

Date : 01/01/2017